Sirio Pharma Co., Ltd. (300791.SZ)
CNY 25.06
(-0.44%)
CNY 25.06
(-0.44%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.62 Billion CNY | 77.16% |
| 2022 | 1.48 Billion CNY | 16.38% |
| 2021 | 1.27 Billion CNY | 173.12% |
| 2020 | 466.94 Million CNY | 12.79% |
| 2019 | 414 Million CNY | -45.49% |
| 2018 | 759.53 Million CNY | 7.34% |
| 2017 | 707.57 Million CNY | -30.14% |
| 2016 | 1.01 Billion CNY | 123.31% |
| 2015 | 453.53 Million CNY | 11.64% |
| 2014 | 406.24 Million CNY | 27.48% |
| 2013 | 318.67 Million CNY | 21.86% |
| 2012 | 261.5 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 2.61 Billion CNY | 2.45% |
| 2024 Q3 | 2.71 Billion CNY | 3.78% |
| 2024 Q1 | 2.54 Billion CNY | -3.05% |
| 2023 FY | 2.62 Billion CNY | 77.16% |
| 2023 Q4 | 2.62 Billion CNY | 36.37% |
| 2023 Q3 | 1.92 Billion CNY | 4.15% |
| 2023 Q2 | 1.85 Billion CNY | 1.8% |
| 2023 Q1 | 1.81 Billion CNY | 22.53% |
| 2022 FY | 1.48 Billion CNY | 16.38% |
| 2022 Q4 | 1.48 Billion CNY | 6.14% |
| 2022 Q3 | 1.39 Billion CNY | 1.96% |
| 2022 Q2 | 1.37 Billion CNY | 6.54% |
| 2022 Q1 | 1.28 Billion CNY | 0.95% |
| 2021 Q4 | 1.27 Billion CNY | -5.47% |
| 2021 Q2 | 1.33 Billion CNY | 168.87% |
| 2021 FY | 1.27 Billion CNY | 173.12% |
| 2021 Q1 | 495.91 Million CNY | 6.2% |
| 2021 Q3 | 1.34 Billion CNY | 1.18% |
| 2020 Q2 | 475.03 Million CNY | -5.28% |
| 2020 Q3 | 525.39 Million CNY | 10.6% |
| 2020 Q1 | 501.53 Million CNY | 21.14% |
| 2020 Q4 | 466.94 Million CNY | -11.12% |
| 2020 FY | 466.94 Million CNY | 12.79% |
| 2019 Q3 | 662.75 Million CNY | -9.07% |
| 2019 FY | 414 Million CNY | -45.49% |
| 2019 Q4 | 414 Million CNY | -37.53% |
| 2019 Q2 | 728.84 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2018 FY | 759.53 Million CNY | 7.34% |
| 2018 Q2 | 769.63 Million CNY | 0.0% |
| 2018 Q4 | 759.53 Million CNY | 0.0% |
| 2017 FY | 707.57 Million CNY | -30.14% |
| 2016 FY | 1.01 Billion CNY | 123.31% |
| 2015 Q3 | 449.23 Million CNY | 0.0% |
| 2015 Q4 | 453.53 Million CNY | 0.96% |
| 2015 FY | 453.53 Million CNY | 11.64% |
| 2014 FY | 406.24 Million CNY | 27.48% |
| 2013 FY | 318.67 Million CNY | 21.86% |
| 2012 FY | 261.5 Million CNY | 0.0% |